Bad medicine: polycystic ovary syndromeBMJ 2010; 341 doi: http://dx.doi.org/10.1136/bmj.c5669 (Published 12 October 2010) Cite this as: BMJ 2010;341:c5669
- Des Spence, general practitioner, Glasgow
About a third of the female population is estimated to have polycystic ovary syndrome, a condition often still called polycystic ovary disease or its scary Teutonic ancestor, Stein-Leventhal syndrome (BMJ 2009;338:a2968, doi:10.1136/bmj.a2968). It is linked to infertility, is considered a metabolic prediabetic syndrome, and is linked with oestrogenic tumours of the breast and endometrium. The syndrome is widely treated, and drugs such as metformin, rosiglitazone (now recognised to have adverse effects), and simvastatin have been used. It has filled many a column inch and sold millions of magazines by …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial